FDA Approved: MECLOFENAMATE SODIUM — Supplemental Application (Mylan Pharmaceuticals Inc.)

View source ↗

Summary

FDA approved a supplemental application for meclofenamate sodium from Mylan Pharmaceuticals Inc.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dysmenorrhea
• Osteoarthritis
• Rheumatoid Arthritis

Drugs mentioned

• Meclofenamate sodium (meclofenamate sodium)

Snippet

SUPPL AP for MECLOFENAMATE SODIUM (MECLOFENAMATE SODIUM)